newsfilter
← Latest News
GlobeNewswire·

Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026

THE WOODLANDS, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), a leading cardiometabolic biopharmaceutical company, today announced the Company will release its third quarter